ATE106399T1 - Sulfonamidderivate, inhibitoren für das aldose- reduktase-enzymsystem und diese enthaltende pharmazeutische zusammenstellungen. - Google Patents

Sulfonamidderivate, inhibitoren für das aldose- reduktase-enzymsystem und diese enthaltende pharmazeutische zusammenstellungen.

Info

Publication number
ATE106399T1
ATE106399T1 AT88115001T AT88115001T ATE106399T1 AT E106399 T1 ATE106399 T1 AT E106399T1 AT 88115001 T AT88115001 T AT 88115001T AT 88115001 T AT88115001 T AT 88115001T AT E106399 T1 ATE106399 T1 AT E106399T1
Authority
AT
Austria
Prior art keywords
enzyme system
chem
reductase enzyme
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT88115001T
Other languages
English (en)
Inventor
Giulio Caccia
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Application granted granted Critical
Publication of ATE106399T1 publication Critical patent/ATE106399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88115001T 1987-09-16 1988-09-14 Sulfonamidderivate, inhibitoren für das aldose- reduktase-enzymsystem und diese enthaltende pharmazeutische zusammenstellungen. ATE106399T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21930/87A IT1223302B (it) 1987-09-16 1987-09-16 Composti solfonamido derivati inibitori del sistema enzimatico aldoso-reduttasi e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ATE106399T1 true ATE106399T1 (de) 1994-06-15

Family

ID=11188976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88115001T ATE106399T1 (de) 1987-09-16 1988-09-14 Sulfonamidderivate, inhibitoren für das aldose- reduktase-enzymsystem und diese enthaltende pharmazeutische zusammenstellungen.

Country Status (9)

Country Link
US (2) US4927849A (de)
EP (1) EP0307879B1 (de)
JP (1) JP2596986B2 (de)
AT (1) ATE106399T1 (de)
AU (1) AU618551B2 (de)
CA (1) CA1332062C (de)
DE (1) DE3889820T2 (de)
IT (1) IT1223302B (de)
ZA (1) ZA886935B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676235B2 (en) * 1992-10-26 1997-03-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Intrinsic inhibitors of aldose reductase
US6117869A (en) * 1998-08-04 2000-09-12 Warner-Lambert Company Compounds for and methods of inhibiting matrix metalloproteinases
US6607550B1 (en) 2001-09-06 2003-08-19 Anodyne Therapeutics, L.L.C. Method of treating neuropathy using a photo energy device
EP2152258B1 (de) 2007-05-10 2016-05-04 Avalon Pharmaceuticals Fluoren-, anthracen-, xanthen-, dibenzosuberon- und acridinderivate sowie ihre verwendung
US9689841B2 (en) * 2011-08-26 2017-06-27 The Texas A&M University System Fluorescent pI markers for isoelectric focusing separations and fluorescent labeling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1485648A (fr) * 1966-05-06 1967-06-23 Procédé pour la préparation de sulfamides
US3655470A (en) * 1969-03-29 1972-04-11 Toa Gosei Chem Ind Process for the production of a foamed thermoplastic resin sheet
US3849565A (en) * 1972-01-12 1974-11-19 Syntex Inc Disubstituted xanthone carboxylic acid compounds for inhibiting asthma
CA1072359A (en) * 1974-10-08 1980-02-26 Hiroyuki Konishi Method for controlling the growth of plants
US4232040A (en) * 1978-03-08 1980-11-04 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications

Also Published As

Publication number Publication date
DE3889820T2 (de) 1995-01-12
JP2596986B2 (ja) 1997-04-02
AU618551B2 (en) 1992-01-02
EP0307879A2 (de) 1989-03-22
JPH01110663A (ja) 1989-04-27
US5066676A (en) 1991-11-19
ZA886935B (en) 1989-08-30
EP0307879B1 (de) 1994-06-01
IT1223302B (it) 1990-09-19
AU2227688A (en) 1989-03-16
EP0307879A3 (en) 1990-07-04
IT8721930A0 (it) 1987-09-16
US4927849A (en) 1990-05-22
CA1332062C (en) 1994-09-20
DE3889820D1 (de) 1994-07-07

Similar Documents

Publication Publication Date Title
ES2054020T3 (es) Compuestos biologicamente activos.
EP0313393A3 (de) Benzoxazin-Verbindungen und ihre pharmazeutische Anwendung
ATE90092T1 (de) Thiazolidinon-derivate, ihre herstellung und ihre verwendung.
ATE206709T1 (de) Heterocyclische substituierte benzofuran- harnstoffe
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
MX9403286A (es) Acido valerico substituido.
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
MX9206093A (es) Derivado de oxazolidona
ATE106399T1 (de) Sulfonamidderivate, inhibitoren für das aldose- reduktase-enzymsystem und diese enthaltende pharmazeutische zusammenstellungen.
ATE102621T1 (de) Antirhinovirale (thio)morpholinyl- und piperazinyl-alkylphenolether.
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
NO932815D0 (no) Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater
DE68929321D1 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
IT1216104B (it) Peptidi ad attivita' farmaceutica.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
GR3004095T3 (de)
DE3861273D1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
FR2665362B1 (fr) Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
IT1216103B (it) Peptidi ad attivita' farmaceutica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee